FDAnews Drug Daily Bulletin

Roche’s Avastin Remains Most Requested Drug in UK’s Cancer Drugs Fund

Aug. 31, 2012
A A
Almost a quarter of all applications to the UK’s cancer drugs fund between April 2011 and March 2012 were for Roche’s Avastin, according to figures released by the NHS’ National Cancer Action Team (NCAT).
Pmlive.com